Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

33660 Results Found

Special Bulletin
Public

Updated COVID-19 Prevention, Treatment Information for Clinicians

Details on recent information on treating and preventing COVID-19.
Letter/Comment
Public

AHA Comments on Medpac’s Draft Payment Recommendations for 2023

January 11, 2022 Michael Chernew, Ph.D. Chairman Medicare Payment Advisory Commission 425 I Street, N.W., Suite 701Washington, DC 20001 Dear Dr. Chernew:
Letter/Comment
Public

AHA Urges President to Extend National Emergency Concerning the COVID-19 Pandemic

January 11, 2022  President Joseph R. Biden  The White House  1600 Pennsylvania Avenue, N.W. Washington, DC 20500  Dear President Biden:
Letter/Comment
Public

AHA Urges HHS Secretary to Extend COVID-19 Public Health Emergency Declaration

January 11, 2022 The Honorable Xavier Becerra Secretary U.S. Department of Health and Human Services 200 Independence Avenue, S.W. Washington, D.C. 20201
Other Resources
Public

Data on Variants Supports Getting a COVID-19 Booster, Say MUSC Researchers

Researchers at Charleston, S.C.-based MUSC, who are studying COVID-19 variants, warn of a new surge in cases and urge people to get vaccinated or “boosted.”
Resources

The Clinician Well-being Playbook

   
Event

Info Session on Preventing HAIs

News

Chair File Video: Meet 2022 AHA Board Chair Wright L. Lassiter III

Wright L. Lassiter III is president and CEO of Henry Ford Health System. Lassiter has more than 30 years of experience working in large, complex health systems, including Alameda Health System in Oakland, Calif., Dallas Methodist Health System and JPS Health Network in Fort Worth, Texas.
AHA Center for Health Innovation Market Scan

Why 2022 Will Be a Year of Disruptor Differentiation

If 2021 will be remembered as the great expansion of retail health care, 2022 is likely to be defined as the year of disruptor differentiation.
News

NIH research highlights increased post-COVID-19 risk of pediatric diabetes, Pfizer vaccine’s effectiveness in preventing MIS-C in adolescents and teens

The National Institutes of Health last week released a pair of studies offering fresh insights into COVID-19’s long-term effect on pediatric groups.